There is significant adoption of innovative technology in biotechnology which contributes to the global downstream processing market. Downstream processing refers to the purification and recovery of biosynthetic products, especially in pharmaceuticals from living organisms which includes tissues of animals or plants or fermentation broth. Downstream processing includes the recycling of those components that can be retrieved along with the treatment of disposal of wastage. It is helpful in the manufacturing of antibodies (infliximab and abciximab), antibiotics, natural hormones that are useful in the development of human growth, preparing insulin, vaccine, flavor, natural fragrance compounds, and in the production of industrial enzymes. The global rise in lethal diseases such as dengue, hepatitis, cholera, swine flu and so on will increase the demand for effective vaccination for these fatal diseases.
Browse the full report description of "Downstream Processing Market by Technique (Purification, Clarification and Concentration, and Solid-Liquid Separation) by Product (Chromatography Columns and Resins, Filters, Single-Use Products, Membrane Absorbers, and Others) by Application (Monoclonal Antibody (MABS) Production, Insulin Production, Vaccine Production, and Others) – Global Trends, Industry Size, Share, Growth, and Forecast, 2019-2025" at https://www.omrglobal.com/industry-reports/downstream-processing-market
The growing biotechnology sector is the major factor propelling the demand for the market. The rise in the downstream processing market is also attributed to the high adoption of biotech processing majorly in the agricultural, pharmaceutical and bio service. Rising demand for the high yield variety of seeds and other advancement is due to the development in the field of genetic engineering and gene therapy. Major players of global downstream processing industry endeavor to streamline the process and try to cut down the overall cost associated with the procedural cost and raw material which will ultimately reduce the overall price of the products.
R&D investments are on the rise and the evolution of new downstream processing technology will further help in the development of the market. However, product life degradation, regulatory directives, and strict licensing policies can be a restraint for the downstream processing market. Major downstream processing techniques include member affinity chromatography, employment of high throughput process development, perfusion chromatography, and single-use systems. Moreover, growing investment in the development of bioprocess and fermentation technology for supporting large level production of biologics and biosimilar is expected to boost the growth of the downstream processing market.
Scope of inducing downstream processing technique for the commercial production of the biodegradable material has been increasing, owing to the development of the biosimilar. Contract Manufacturing Organizations (CMOs) are playing a distinctive role in the overall development of the market. A new pharma plant, that is equipped with the large stainless-steel bioreactor to produce large-volume biopharmaceuticals is expensive and time-consuming. Therefore, new market entrants, including startups and some large companies in their expansion programs are switching to CMOS rather than acquiring their own production house.
Current Market Trends Covered in the Report
Global Downstream Processing Market: - Segmentation
By Product
By Application
Global Downstream Processing Market: - Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/downstream-processing-market